News Daily News RE-LY: Dabigatran Shortens Drug Interruption with No Increased Bleeding Jason Kahn June 22, 2012
News Industry News Regado Biosciences, Inc. Presents Positive Efficacy and Safety Substudy Data from the Phase 2b RADAR Trial for the REG1 Anticoagulation System November 06, 2011